EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Use of the 445‐nm Blue Laser for Management of Early Glottic Carcinoma: Preliminary 1‐Year Results

David E Rosow iD, Eytan Keidar iD, Luke J Pasick, Nicolas J Casellas, Mursalin M Anis

The Laryngoscope · 2024

DOI: 10.1002/lary.31569 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Laryngoscope, 2024. Verfasst von David E Rosow und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Glottis, Lasers, Solid-State, Laser Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To analyze oncological efficacy and voice outcomes of the 445‐nm blue laser (BL) in the treatment of early glottic carcinoma and compare results with the 532‐nm potassium‐titanyl‐phosphate (KTP) laser. Study Design Single institution, retrospective chart review.

Methods

All patients who underwent microlaryngoscopic KTP or BL laser excision of early glottic carcinoma from 2018 to the present day with at least 1‐year follow‐up were included. Primary and recurrent disease, including radiation and surgical failures, were included. Demographic data, voice outcomes and oncologic outcomes were compared between the two laser groups.

Results

Forty‐nine patients met the inclusion criteria for the BL group and 88 for the KTP group, with average follow‐up of 635 and 1236 days, respectively. Oncologic outcomes were not significantly different, with disease‐specific survival rates of 95.9% for BL and 100% for KTP ( p = 0.13), organ preservation rates of 98.0% for BL and 95.6% for KTP ( p = 0.39), and local control rates of 93.9% for BL and 92.1% for KTP ( p = 0.81). Both BL and KTP groups showed significant improvement in CAPE‐V ( p = 0.04, 0.006 respectively) and VHI‐10 scores ( p = 0.003,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsGlottisLasers, Solid-StateLaser TherapyHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTreatment OutcomeLaryngoscopyFollow-Up StudiesAged, 80 and overAdultVoice Quality

Stichwörter der Autor:innen

KTP laserblue laserglottic cancerlaryngeal cancerlaser

Autor:innen und Institutionen

  • Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, USA.

ORCID-Profile: David E Rosow, Eytan Keidar

Zitieren

APA

Rosow, D. E., Keidar, E., Pasick, L. J., Casellas, N. J., & Anis, M. M. (2024). Use of the 445‐nm Blue Laser for Management of Early Glottic Carcinoma: Preliminary 1‐Year Results. The Laryngoscope. https://doi.org/10.1002/lary.31569

Vancouver

Rosow DE, Keidar E, Pasick LJ, Casellas NJ, Anis MM. Use of the 445‐nm Blue Laser for Management of Early Glottic Carcinoma: Preliminary 1‐Year Results. The Laryngoscope. 2024. doi:10.1002/lary.31569

BibTeX
@article{Rosow2024,
  author = {Rosow, David E and Keidar, Eytan and Pasick, Luke J and Casellas, Nicolas J and Anis, Mursalin M},
  title = {Use of the 445‐nm Blue Laser for Management of Early Glottic Carcinoma: Preliminary 1‐Year Results},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.31569}
}
Kostenlos starten →